The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Stadler, Walter M.
One or more keywords matched the following properties of Stadler, Walter M.
PropertyValue
keywords Bladder Cancer
keywords Prostate Cancer
keywords Renal Cancer
overview Dr. Stadler is a clinical trialist focused on developing novel therapies and biomarkers, especially for genitourinary cancer. In addition to an extensive history performing trials in kidney, bladder, and prostate cancer, he also has broad experience in leading efforts supporting clinical trial infrastructure and conduct. These include renal cancer cadre leader for the Cancer and Leukemia Group B (CALGB, now Alliance), PI for a DOD funded prostate cancer clinical trials consortium, co-PI for a Prostate Cancer SPORE, PI for the NCI funded N01 contract for early phase clinical trials, and a current role as Dean for Clinical Research
One or more keywords matched the following items that are connected to Stadler, Walter M.
Item TypeName
Concept Adrenal Cortex Neoplasms
Concept Breast Neoplasms
Concept Bone Neoplasms
Concept Urinary Bladder Neoplasms
Concept Fallopian Tube Neoplasms
Concept Colonic Neoplasms
Concept Uterine Cervical Neoplasms
Concept Kidney Neoplasms
Concept Neoplasms, Hormone-Dependent
Concept Liver Neoplasms
Concept Pelvic Neoplasms
Concept Pancreatic Neoplasms
Concept Ovarian Neoplasms
Concept Lung Neoplasms
Concept Mediastinal Neoplasms
Concept Prostatic Neoplasms
Concept Pleural Neoplasms
Concept Head and Neck Neoplasms
Concept Urologic Neoplasms
Concept Ureteral Neoplasms
Concept Meningeal Neoplasms
Concept Cancer Vaccines
Concept Peritoneal Neoplasms
Concept National Cancer Institute (U.S.)
Concept Colorectal Neoplasms
Concept Thyroid Neoplasms
Concept Muscle Neoplasms
Concept Neoplasms
Concept Urogenital Neoplasms
Academic Article High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experience.
Academic Article Human renal cancer carcinogenesis: a review of recent advances.
Academic Article Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer.
Academic Article Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.
Academic Article Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.
Academic Article Overcoming cellular senescence in human cancer pathogenesis.
Academic Article Expression of bcl-2 and bcl-X in bladder cancer.
Academic Article Prostate cancer metastasis-suppressor genes: a current perspective.
Academic Article Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract.
Academic Article Study of cohort-specific consent and patient control in phase I cancer trials.
Academic Article The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
Academic Article Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator.
Academic Article Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
Academic Article Metastatic bladder cancer: advances in treatment.
Academic Article A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.
Academic Article Cytokine therapy in metastatic renal cancer.
Academic Article Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization.
Academic Article New chemotherapy regimens for advanced bladder cancer.
Academic Article [New chemotherapy regimens for advanced bladder cancer].
Academic Article Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.
Academic Article Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.
Academic Article Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.
Academic Article Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.
Academic Article Development of target-based antineoplastic agents.
Academic Article Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.
Academic Article Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential.
Academic Article Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Academic Article Kidney cancer.
Academic Article Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
Academic Article In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Academic Article Treatment of metastatic urothelial cancer in the post-MVAC era.
Academic Article Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
Academic Article In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.
Academic Article Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
Academic Article Gemcitabine doublets in advanced urothelial cancer.
Academic Article Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Academic Article Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.
Academic Article A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma.
Academic Article Renal cancer immunotherapy: a ray of hope or regression to the mean?
Academic Article Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations.
Academic Article Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.
Academic Article Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Academic Article Docetaxel and exisulind in hormone-refractory prostate cancer.
Academic Article Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
Academic Article New trial designs to assess antitumor and antiproliferative agents in prostate cancer.
Academic Article Randomized study of three different doses of suramin administered with a fixed dosing schedule in patients with advanced prostate cancer: results of intergroup 0159, cancer and leukemia group B 9480.
Academic Article A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer.
Academic Article Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Perioperative chemotherapy in locally advanced bladder cancer.
Academic Article Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Academic Article A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
Academic Article Angiogenesis inhibitors.
Academic Article Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Academic Article Acute bilateral abducens paralysis due to oxaliplatin.
Academic Article Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.
Academic Article Angiogenesis inhibitors in genitourinary cancers.
Academic Article Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
Academic Article Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Academic Article Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma.
Academic Article Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.
Academic Article Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.
Academic Article 9-Nitrocamptothecin as second line chemotherapy for men with progressive, metastatic, hormone refractory prostate cancer: Results of the CALGB 99901.
Academic Article A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer.
Academic Article Randomized discontinuation design: application to cytostatic antineoplastic agents.
Academic Article Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
Academic Article Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.
Academic Article Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
Academic Article Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Academic Article Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysis.
Academic Article A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
Academic Article Randomized phase II trials and prostate-specific antigen endpoints in prostate cancer: much ado about nothing?
Academic Article A Phase II study of oxaliplatin in urothelial cancer.
Academic Article Do elderly patients have a worse outcome in response to platinum-based therapy for metastatic urothelial cancer?
Academic Article A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
Academic Article The role of systemic chemotherapy in the treatment of kidney cancer.
Academic Article Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Academic Article Cytotoxic chemotherapy for metastatic renal cell carcinoma.
Academic Article Targeted agents for the treatment of advanced renal cell carcinoma.
Academic Article Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Academic Article Development of growth inhibitory agents in urological and other malignancies.
Academic Article Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.
Academic Article The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
Academic Article A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
Academic Article A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
Academic Article Sorafenib in advanced clear-cell renal-cell carcinoma.
Academic Article Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
Academic Article Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Academic Article Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid.
Academic Article Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma.
Academic Article Multiple reference tissue method for contrast agent arterial input function estimation.
Academic Article Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Academic Article A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
Academic Article Innovations and challenges in renal cancer: consensus statement from the first international conference.
Academic Article Therapeutic options for variant renal cancer: a true orphan disease.
Academic Article A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer.
Academic Article Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
Academic Article The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.
Academic Article Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design.
Academic Article Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Academic Article A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies.
Academic Article Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
Academic Article A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors.
Academic Article An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Academic Article Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Academic Article Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862): trial results and interleukin-6 analysis: a study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium.
Academic Article Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study.
Academic Article A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.
Academic Article A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.
Academic Article Reproducibility assessment of a multiple reference tissue method for quantitative dynamic contrast enhanced-MRI analysis.
Academic Article Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study.
Academic Article Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy.
Academic Article Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.
Academic Article Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.
Academic Article A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Academic Article Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
Academic Article A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.
Academic Article New therapeutic options for renal cell carcinoma.
Academic Article Sorafenib.
Academic Article Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Academic Article New targets, therapies, and toxicities: lessons to be learned.
Academic Article Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy.
Academic Article Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial.
Academic Article Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
Academic Article Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.
Academic Article Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
Academic Article Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America.
Academic Article Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.
Academic Article Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Academic Article A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation.
Academic Article Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses.
Academic Article Portable filter-based microdevice for detection and characterization of circulating tumor cells.
Academic Article Fuzzy thinking on biomarkers.
Academic Article Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program.
Academic Article Prognostic factors in localized renal cell cancer.
Academic Article Phase I dose escalation and pharmacokinetic study of AZD2171, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinase, in patients with hormone refractory prostate cancer (HRPC).
Academic Article A phase I study of continuous infusion cilengitide in patients with solid tumors.
Academic Article A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer: results from Cancer and Leukemia Group B Study 90006.
Academic Article Bevacizumab and everolimus in renal cancer: a rational way forward.
Academic Article A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Academic Article Adjuvant chemotherapy in lymph node positive bladder cancer.
Academic Article Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Academic Article Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206.
Academic Article FYN is overexpressed in human prostate cancer.
Academic Article Effective therapy for metastatic renal cancer, whither to now.
Academic Article Recommended changes to oncology clinical trial design: revolution or evolution?
Academic Article Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.
Academic Article Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Academic Article Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
Academic Article MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure.
Academic Article Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.
Academic Article A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
Academic Article Developing drugs that do not cause tumor regression.
Academic Article Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC).
Academic Article Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.
Academic Article Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer.
Academic Article Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.
Academic Article Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.
Academic Article Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence.
Academic Article Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21.
Academic Article A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
Academic Article Molecular events in the initiation and progression of bladder-cancer (review).
Academic Article A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia.
Academic Article Randomized phase II trials: a long-term investment with promising returns.
Academic Article Multicenter phase II trial of the heat shock protein 90 inhibitor, retaspimycin hydrochloride (IPI-504), in patients with castration-resistant prostate cancer.
Academic Article Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
Academic Article Dynamic contrast-enhanced MR imaging findings of bone metastasis in patients with prostate cancer.
Academic Article Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Academic Article Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
Academic Article The cure of bladder cancer: the need for multidisciplinary efforts.
Academic Article Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review.
Academic Article Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
Academic Article Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapy.
Academic Article Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Academic Article Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Academic Article Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells.
Academic Article Pazopanib in renal cell carcinoma.
Academic Article Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Academic Article A trial postmortem: challenges in conducting a randomized, double-blind, phase 2 study in men with castration-resistant prostate cancer.
Academic Article Increased p16 levels correlate with pRb alterations in human urothelial cells.
Academic Article Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
Academic Article Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.
Academic Article Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Academic Article Nilutamide: possible utility as a second-line hormonal agent.
Academic Article A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.
Academic Article Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
Academic Article Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159/Cancer and Leukemia Group B 9480.
Academic Article Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Academic Article A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer.
Academic Article A molecular classification of papillary renal cell carcinoma.
Academic Article Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Academic Article Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
Academic Article A phase II study of depsipeptide in refractory metastatic renal cell cancer.
Academic Article Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.
Academic Article Angiogenesis inhibition in non-clear cell renal cancer.
Academic Article Prognosis and prediction in a Facebook world.
Academic Article Other paradigms: randomized discontinuation trial design.
Academic Article Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer.
Academic Article A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
Academic Article Novel approaches and future directions in castration-resistant prostate cancer.
Academic Article Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study.
Academic Article Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
Academic Article Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.
Academic Article Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures.
Academic Article Renal cancer therapeutics: now what?
Academic Article Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Academic Article ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.
Academic Article Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials.
Academic Article MR imaging-guided focal laser ablation for prostate cancer: phase I trial.
Academic Article Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging.
Academic Article Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis.
Academic Article Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.
Academic Article Low-grade prostate cancer diverges early from high grade and metastatic disease.
Academic Article Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma.
Academic Article Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).
Academic Article Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.
Academic Article An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.
Academic Article Predictive markers in advanced renal cell carcinoma.
Academic Article The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (Alliance).
Academic Article Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Academic Article Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
Academic Article Phase I/II trial of orteronel (TAK-700)--an investigational 17,20-lyase inhibitor--in patients with metastatic castration-resistant prostate cancer.
Academic Article Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.
Academic Article Double-blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma.
Academic Article Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
Academic Article The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial.
Academic Article A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
Academic Article WITHDRAWN: Cognitive effects of androgen deprivation therapy in an older cohort of men with prostrate cancer.
Academic Article Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.
Academic Article A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.
Academic Article Maturing of renal cancer therapeutics.
Academic Article FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
Academic Article Optimal use of imaging to guide treatment decisions for kidney cancer.
Academic Article Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
Academic Article Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance).
Academic Article Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?
Academic Article Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer.
Academic Article A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer.
Academic Article Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
Academic Article First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70.
Academic Article Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Academic Article Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Academic Article Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Academic Article Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Academic Article Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.
Academic Article Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.
Academic Article The Role of Testosterone in the Treatment of Castration-Resistant Prostate Cancer.
Academic Article Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.
Academic Article Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Academic Article Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.
Academic Article Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial.
Academic Article Phase II trial of adjuvant gemcitabine plus cisplatin (GC) with amifostine cytoprotection in patients (pts) with locally advanced bladder cancer (BC).
Academic Article Sequential axitinib (AG-013736) therapy of patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sunitinib and sorafenib, cytokines and sorafenib, or sorafenib alone.
Academic Article Final analysis of a randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC).
Academic Article Markers of bone metabolism predict survival in hormone refractory prostate cancer (HRPC): Results from a randomized California Cancer Consortium & University of Chicago trial.
Academic Article Phase II study of bortezomib in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital [PMH] Phase II Consortium.
Academic Article Older cancer survivors' use of biologically based complementary and alternative medicine (CAM): A national, population-based study in the United States.
Academic Article A phase II study of depsipeptide (Dep) in patients (pts) with metastatic renal cell cancer (RCC).
Academic Article Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Academic Article Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Academic Article Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.
Academic Article Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer.
Academic Article Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer.
Academic Article Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.
Academic Article Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).
Academic Article Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
Academic Article Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
Academic Article Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.
Academic Article Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Academic Article Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Academic Article Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Academic Article Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy.
Academic Article The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Academic Article Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Academic Article Management of Urothelial Bladder Cancer: Predicting the Future.
Academic Article EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells.
Academic Article A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Academic Article Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma.
Academic Article A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
Academic Article No interest, no conflict.
Academic Article Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case.
Academic Article Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer.
Academic Article Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Academic Article Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.
Academic Article Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Academic Article Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
Academic Article Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma.
Academic Article A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Academic Article Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial.
Academic Article Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial.
Academic Article Knowledge and distress in complex cancer care.
Academic Article Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
Academic Article NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases.
Academic Article Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.
Academic Article Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer.
Academic Article Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
Academic Article Emerging targets in kidney cancer: opportunities for drug development.
Academic Article Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors.
Academic Article A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer.
Concept Prostatic Neoplasms, Castration-Resistant
Academic Article Enrollment Barriers for Molecular Targeted Trials.
Academic Article A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Academic Article Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics.
Academic Article PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Academic Article Optimizing the doses of cancer drugs after usual dose finding.
Academic Article Bladder-Preserving Trimodality Therapy With Capecitabine.
Academic Article A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer.
Academic Article There Is More to Length of Survival Than Survival: Endpoints in Oncology Trials.
Academic Article Feasibility of structuring electronic health record data to facilitate real-world data research: ICAREdata methods applied to multicenter cancer clinical trials.
Academic Article Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Academic Article Drug dosing in cancer patients with decreased kidney function: A practical approach.
Search Criteria
  • Cancer